Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes

Michalopoulos, 2008, Colistin and polymyxin B in critical care, Crit Care Clin, 24, 377, 10.1016/j.ccc.2007.12.003 Pogue, 2011, Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system, Clin Infect Dis, 53, 879, 10.1093/cid/cir611 Hartzell, 2009, Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center, Clin Infect Dis, 48, 1724, 10.1086/599225 Tuon, 2014, Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium, Int J Antimicrob Agents, 43, 349, 10.1016/j.ijantimicag.2013.12.002 DeRyke, 2010, Colistin dosing and nephrotoxicity in a large community teaching hospital, Antimicrob Agents Chemother, 54, 4503, 10.1128/AAC.01707-09 Rocco, 2013, Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study, Crit Care, 17, R174, 10.1186/cc12853 Falagas, 2005, Toxicity after prolonged (more than four weeks) administration of intravenous colistin, BMC Infect Dis, 5, 1, 10.1186/1471-2334-5-1 Weinstein, 2005, Overview of nosocomial infections caused by Gram-negative bacilli, Clin Infect Dis, 41, 848, 10.1086/432803 Kim, 2014, Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea, Diagn Microbiol Infect Dis, 78, 457, 10.1016/j.diagmicrobio.2013.08.011 Garnacho-Montero, 2003, Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP, Clin Infect Dis, 36, 1111, 10.1086/374337 Bellomo, 2004, Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group, Crit Care, 8, R204, 10.1186/cc2872 Charlson, 1987, Morbidity during hospitalization: can we predict it?, J Chronic Dis, 40, 705, 10.1016/0021-9681(87)90107-X Knaus, 1985, APACHE II: a severity of disease classification system, Crit Care Med, 13, 818, 10.1097/00003246-198510000-00009 Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 60, 4 National Kidney Foundation, 2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1 Kim, 2011, Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection, Am J Respir Crit Care Med, 183, 1207, 10.1164/rccm.201101-0110OC Evans, 1999, Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria, Ann Pharmacother, 33, 960, 10.1345/aph.18426 Clinical Laboratory Standards Institute, 2011 Vicari, 2013, Association between colistin dose and microbiologic outcomes in patient with multidrug-resistant Gram-negative bacteremia, Clin Infect Dis, 56, 398, 10.1093/cid/cis909 Falagas, 2010, Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients, Int J Antimicrob Agents, 35, 194, 10.1016/j.ijantimicag.2009.10.005 Couet, 2012, Colistin pharmacokinetics: the fog is lifting, Clin Microbiol Infect, 18, 30, 10.1111/j.1469-0691.2011.03667.x Garonzik, 2011, Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients, Antimicrob Agents Chemother, 55, 3284, 10.1128/AAC.01733-10 Lameire, 2013, Acute kidney injury: an increasing global concern, Lancet, 382, 170, 10.1016/S0140-6736(13)60647-9 Hines, 2009, Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer, J Clin Oncol, 27, 4339, 10.1200/JCO.2009.22.4758 Ali, 2007, Incidence and outcomes in acute kidney injury: a comprehensive population-based study, J Am Soc Nephrol, 18, 1292, 10.1681/ASN.2006070756 Portella, 2013, Sepsis-surviving mice are more susceptible to a secondary kidney insult, Crit Care Med, 41, 1056, 10.1097/CCM.0b013e3182746696 Bagshaw, 2009, Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy, Intensive Care Med, 35, 871, 10.1007/s00134-008-1367-2 Turkoglu, 2012, Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction, Int J Antimicrob Agents, 39, 142, 10.1016/j.ijantimicag.2011.10.006 Sprung, 2008, Hydrocortisone therapy for patients with septic shock, N Engl J Med, 358, 111, 10.1056/NEJMoa071366 Annane, 2002, Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock, JAMA, 288, 862, 10.1001/jama.288.7.862